-
1 Comment
CardioComm Solutions, Inc is currently in a long term downtrend where the price is trading 20.0% below its 200 day moving average.
From a valuation standpoint, the stock is 98.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 11.0.
CardioComm Solutions, Inc's total revenue sank by 25.5% to $186K since the same quarter in the previous year.
Its net income has increased by 86.6% to $-14K since the same quarter in the previous year.
Finally, its free cash flow grew by 24.9% to $28K since the same quarter in the previous year.
Based on the above factors, CardioComm Solutions, Inc gets an overall score of 3/5.
| ISIN | CA14159N2086 |
|---|---|
| Sector | Healthcare |
| Industry | Health Information Services |
| Exchange | V |
| CurrencyCode | CAD |
| Market Cap | 3M |
|---|---|
| Beta | -1.02 |
| PE Ratio | None |
| Target Price | None |
| Dividend Yield | None |
CardioComm Solutions, Inc. develops advanced software and hardware products, and core laboratory reading services related to electrocardiogram (ECG) and ambulatory arrhythmia monitoring systems for medical and consumer markets worldwide. It offers consumer health monitoring products, including GEMS mobile ECG, GEMS mobile RPM, HeartCheck CardiBeat " Mobile ECG device, and HeartCheck SMART monitoring. The company also provides healthcare professional monitoring products, such as GEMS Sirona, GEMS WIN, and Trident Pro 40L. CardioComm Solutions, Inc. was incorporated in 1989 and is headquartered in Toronto, Canada.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for EKG.V using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
